ARS Pharmaceuticals, Inc. SPRY
3.05 USD 0.00 (+0.00%)
At closeNov 4, 2026, 5:45 AM EST
2.85 -0.20 -6.56%
Pre-market · Nov 4, 5:45 AM ET
2.92 Day range 3.11
2.91 52-week range 13.15
- YTD
- -73.82%
- 1 year
- -64.98%
Held by funds
63 US ETFs and mutual funds hold SPRY · largest positions
Ownership
Held by insiders 16.21%
Held by institutions 95.47%
Float held by institutions 113.94%
Institutions 275
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 10.94% | 10,860,977 | 114.47M | Mar 30, 2026 |
| Orbimed Advisors LLC. | 8.35% | 8,288,510 | 87.36M | Mar 30, 2026 |
| Rubric Capital Management LP | 8.06% | 8,000,000 | 84.32M | Mar 30, 2026 |
| Deerfield Management Company, L.P | 7.56% | 7,503,812 | 79.09M | Mar 30, 2026 |
| Millennium Management Llc | 6.02% | 5,982,919 | 63.06M | Mar 30, 2026 |
| Blackrock Inc. | 5.05% | 5,012,254 | 52.83M | Mar 30, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.44% | 2,418,584 | 25.49M | May 30, 2026 |
| abrdn Healthcare Opportunities Fund | 1.80% | 1,783,628 | 18.80M | Mar 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.76% | 1,749,763 | 18.44M | Mar 30, 2026 |
| abrdn Healthcare Investors | 1.56% | 1,548,014 | 16.32M | Mar 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.40% | 1,393,126 | 14.68M | Apr 29, 2026 |
| BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. | 1.08% | 1,074,609 | 11.33M | Mar 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| FITZPATRICK ALEXANDER A. | Officer | Sale | Jun 11, 2026 | 90,910 |
| FLYNN JAMES E | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 26, 2025 | 0 |
| KARAS ERIC | Officer | Sale | Jun 11, 2026 | 12,176 |
| LOWENTHAL RICHARD E | Chief Executive Officer | Sale | Aug 20, 2025 | 0 |
| ORBIMED ADVISORS, L.L.C. | Unknown | Sale | Aug 25, 2024 | 0 |
| SCOTT KATHLEEN D | Chief Financial Officer | Sale | Aug 20, 2025 | 18,292 |
